Sobhan Vinjamuri

Suggest Changes
Learn More
Advanced pancreatic cancer has a poor prognosis, and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage. However the drawback is the accompanying(More)
BACKGROUND Ga-DOTA-conjugated peptide PET/CT is used widely for diagnosis and treatment planning in patients with neuroendocrine tumours. As nephrotoxicity is a major limiting factor during peptide(More)
Neuroendocrine tumors (NETs) of midgut origin (referred to as carcinoid tumors) usually arise from the terminal ileum or appendix, and commonly metastasize to the liver, lungs, or bone. Ocular(More)